首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Atezolizumab/bevacizumabLack of efficacy
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2024年
/ 2006卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-024-57999-4
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:104 / 104
相关论文
共 50 条
[41]
Atezolizumab/DocetaxelInterstitial pneumonitis and lack of efficacy
Reactions Weekly,
2024,
1998
(1)
: 85
-
85
[42]
Atezolizumab/Bevacizumab/LenvatinibPseudoaneurysm and lack of efficacy
Reactions Weekly,
2024,
2004
(1)
: 70
-
70
[43]
Atezolizumab/carboplatin/etoposideLack of efficacy: case report
Reactions Weekly,
2022,
1918
(1)
: 80
-
80
[44]
Atezolizumab/carboplatin/etoposideVarious toxicities and lack of efficacy
Reactions Weekly,
2024,
2003
(1)
: 136
-
136
[45]
Atezolizumab/Dabrafenib/TrametinibOptic neuropathy and lack of efficacy
Reactions Weekly,
2024,
2007
(1)
: 69
-
69
[46]
Atezolizumab/carboplatin/etoposideLack of efficacy: case report
Reactions Weekly,
2023,
1970
(1)
: 54
-
54
[47]
Atezolizumab/carboplatin/etoposideLack of efficacy: case report
Reactions Weekly,
2023,
1978
(1)
: 80
-
80
[48]
Atezolizumab/carboplatin/etoposideLack of efficacy: case report
Reactions Weekly,
2023,
1959
(1)
: 114
-
114
[49]
Atezolizumab/bevacizumabIntratumour haemorrhage followed by lack of efficacy
Reactions Weekly,
2024,
2013
(1)
: 68
-
68
[50]
Atezolizumab/Methylprednisolone/TocilizumabSecondary haemophagocytic lymphohistiocytosis and lack of efficacy
Reactions Weekly,
2024,
2009
(1)
: 92
-
92
←
1
2
3
4
5
→